Topic: Prostate Cancer
Shares of Dendreon (DNDN) traded down sharply earlier this morning on reports that it would be subject to a surprise, unexpected additional FDA advisory panel.
The stock sold off hard, as any unanticipated news spooks investors with this company. Their drug Provenge has shown dramatic results extending the lives of those with advanced prostate cancer, and is widely believed to ...
Prostate cancer patients who take statins to lower their cholesterol may be getting a secondary benefit: The drugs significantly lower the degree of inflammation within prostate tumors. That, according to researchers, may explain in part, why men on statins have a lower risk of disease progression. Previous studies have shown that statins reduce systemic ...
NEW YORK (Reuters Health) - Robot-assisted laparoscopic, or "keyhole," surgery appears to be no better at reducing side effects than traditional "open" surgery to remove a cancerous prostate gland, according to new study from Memorial Sloan-Kettering Cancer Center in New York. Critics, however, claim the study relied on old data that doesn't reflect current practice. Typically, in traditional open radical ...
Given the bind that many prominent American men have thrust themselves into — think Tiger Woods, Mark Sanford, Eliot Spitzer, et al. — it seems it really is possible to have too much of a good thing. And your prostate gland appears to agree. According to a new research out of the UK, men who have frequent sex in their twenties and ...
